Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 60, Issue 4, 2017, Pages 1241-1257

  Zhang, Ling ^a,b   Wang, Ying ^a,b   Xiayu, Xia ^a,b   Shi, Changhua ^a,b   Chen, Wei ^a,b   Song, Nan ^a,b   Fu, Xinjing ^a,b   Zhou, Rui ^a,b   Xu, Yan Feng ^a,b   Huang, Lan ^a,b   Zhu, Hua ^a,b   Han, Yunlin ^a,b   Qin, Chuan ^a,b  

^a BEIJING HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

aging; Alzheimer's disease; gut microbiota; mouse model; short chain fatty acids

Indexed keywords

ACETIC ACID; AMYLOID; AMYLOID BETA PROTEIN ANTIBODY; BUTYRIC ACID; ISOBUTYRIC ACID; ISOVALERIC ACID; PHOSPHATIDYLINOSITOL; PROPIONIC ACID; SHORT CHAIN FATTY ACID; THIOFLAVINE; VALERIC ACID; VOLATILE FATTY ACID;

ACTINOBACTERIA; ALLOBACULUM; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIUM; BIOINFORMATICS; BRAIN FUNCTION; BUTYRICICOCCUS PULLICAECORUM; COGNITIVE DEFECT; CONTROLLED STUDY; COPROCOCCUS; DESULFOVIBRIO; ERYSIPELOTRICHACEAE; ERYSIPELOTRICHALES; FECES MICROFLORA; FIRMICUTES; HIGH THROUGHPUT SEQUENCING; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; LIPID COMPOSITION; MALE; MICROBIAL COMMUNITY; MICROFLORA; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; OSCILLOSPIRA; PARABACTEROIDES; PARABACTEROIDES DISTASONIS; PARAPREVOTELLA; PHYLUM; PRIORITY JOURNAL; ROSEBURIA; RUMINOCOCCUS; TRANSMISSION ELECTRON MICROSCOPY; VERRUCOMICROBIA; AGING; ANIMAL; BIOLOGY; CHEMISTRY; DISEASE MODEL; FECES; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOLOGY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; ANIMALS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; FATTY ACIDS, VOLATILE; FECES; GASTROINTESTINAL MICROBIOME; INTESTINES; MALE; MICE, TRANSGENIC;

EID: 85033601509     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-170020     Document Type: Article

References (72)

1. Alzheimer's Association (2016) 2016 Alzheimer's disease facts and figures. Alzheimers Dement 12, 459-509.
2. Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, Xie P, Morrison M, Wesselingh SL, Rogers GB, Licinio J (2016) Inflammasome signaling affects anxiety-and depressive-like behavior and gut microbiome composition. Mol Psychiatry 21, 797-805.
3. O'Toole PW, Jeffery IB (2015) Gut microbiota and aging. Science 350, 1214-1215.
4. Cryan JF, Dinan TG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13, 701-712.
5. Naseer MI, Bibi F, AlqahtaniMH, ChaudharyAG, Azhar EI, Kamal MA, Yasir M (2014) Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease. CNS Neurol Disord Drug Targets 13, 305-311.
6. Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S (2016) From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol Psychiatry 21, 738-748.
7. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, Forslund K, Hildebrand F, Prifti E, Falony G, Le Chatelier E, Levenez F, Dore J, Mattila I, Plichta DR, Poho P, Hellgren LI, Arumugam M, Sunagawa S, Vieira-Silva S, Jorgensen T, Holm JB, Trost K, Kristiansen K, Brix S, Raes J, Wang J, Hansen T, Bork P, Brunak S, Oresic M, Ehrlich SD, PedersenO(2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535, 376-381.
8. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167, 915-932.
9. Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 6, e28032.
10. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P (2015) Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30, 350-358.
11. Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167, 1469-1480 e1412.
12. Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao Y, Lukiw WJ (2014) Pathogenic microbes, the microbiome, and Alzheimer's disease (AD). Front Aging Neurosci 6, 127.
13. Hill JM, Lukiw WJ (2015) Microbial-generated amyloids and Alzheimer's disease (AD). Front Aging Neurosci 7, 9.
14. Zhao Y, Lukiw WJ (2015) Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD). J Nat Sci 1, pii: e138.
15. Zhao Y, Dua P, Lukiw WJ (2015) Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer's disease (AD). J Alzheimers Dis Parkinsonism 5, 177.
16. Pistollato F, Sumalla Cano S, Elio I, Masias Vergara M, Giampieri F, Battino M (2016) Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev 74, 624-634.
17. Lukiw WJ (2016) Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease. Front Microbiol 7, 1544.
18. Wang D, Ho L, Faith J, Ono K, Janle EM, Lachcik PJ, Cooper BR, Jannasch AH, D'Arcy BR, Williams BA, Ferruzzi MG, Levine S, Zhao W, Dubner L, Pasinetti GM (2015) Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease beta-amyloid oligomerization. Mol Nutr Food Res 59, 1025-1040.
19. Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, Chang EB, Tanzi RE, Sisodia SS (2016) Antibioticinduced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci Rep 6, 30028.
20. Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Hamidi GA, Salami M (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: A randomized, double-blind and controlled trial. Front Aging Neurosci 8, 256.
21. Zhang L, Liu C, Wu J, Tao JJ, Sui XL, Yao ZG, Xu YF, Huang L, Zhu H, Sheng SL, Qin C (2014) Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice. J Alzheimers Dis 41, 1193-1205.
22. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084-1088.
23. Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, Gandy S, Buettner C (2016) Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement 12, 851-861.
24. Zhang C, Kuo CC, Moghadam SH, Monte L, Campbell SN, Rice KC, Sawchenko PE, Masliah E, Rissman RA (2016) Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease. Alzheimers Dement 12, 527-537.
25. Cassir N, Benamar S, Croce O, La Scola B (2016) Clostridium species identification by 16S rRNA pyrosequencing metagenomics. Clin Infect Dis 62, 1616-1618.
26. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R (2011) UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200.
27. Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, Mills DA, Caporaso JG (2013) Qualityfiltering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods 10, 57-59.
28. Edgar RC (2013) UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10, 996-998.
29. Wang Q, Garrity GM, Tiedje JM, Cole JR (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the newbacterial taxonomy. Appl Environ Microbiol 73, 5261-5267.
30. Chao A, Chazdon RL, Colwell RK, Shen TJ (2006) Abundance-based similarity indices and their estimation when there are unseen species in samples. Biometrics 62, 361-371.
31. Shannon CE (1948) A mathematical theory of communication. Bell Syst Tech J 27, 379-423.
32. Simpson EH (1949) Measurement of diversity. Nature 163, 688.
33. Chao A, Lee SM (1992) Estimating the number of classes via sample coverage. J Am Stat Assoc 87, 210-217.
34. Good IJ (1953) The population frequencies of species and the estimation of population parameters. Biometrika 40, 237-264.
35. Noy-Meir I, AustinMP(1970) Principal component ordination and simulated vegetational data. Ecology 51, 551-552.
36. Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y, Xiang C (2010) Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 11, 488.
37. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
38. Lozupone C, Knight R (2005) UniFrac: A new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71, 8228-8235.
39. Chang Q, Luan Y, Sun F (2011) Variance adjusted weighted UniFrac: A powerful beta diversity measure for comparing communities based on phylogeny. BMC Bioinformatics 12, 118.
40. Lozupone CA, Hamady M, Kelley ST, Knight R (2007) Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 73, 1576-1585.
41. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12, R60.
42. Zeng B, Han S, Wang P, Wen B, Jian W, Guo W, Yu Z, Du D, Fu X, Kong F, Yang M, Si X, Zhao J, Li Y (2015) The bacterial communities associated with fecal types and body weight of rex rabbits. Sci Rep 5, 9342.
43. Zheng X, QiuY, ZhongW, Baxter S, Su M, Li Q, Xie G, Ore BM, Qiao S, Spencer MD, Zeisel SH, Zhou Z, Zhao A, Jia W (2013) A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics 9, 818-827.
44. Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, Davey G, Moritz E, Nitsch RM (2002) Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med 8, 1270-1275.
45. Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, Roy R, Singh S (2005) Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol 151, 229-238.
46. Langille MG, Meehan CJ, Koenig JE, Dhanani AS, Rose RA, Howlett SE, Beiko RG (2014) Microbial shifts in the aging mouse gut. Microbiome 2, 50.
47. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, Fitzgerald GF, Deane J, O'Connor M, Harnedy N, O'Connor K, O'Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O'Toole PW (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184.
48. Shin NR, Whon TW, Bae JW (2015) Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 33, 496-503.
49. Park H, Bell H, Hotte N, Madsen K (2016) Su1888 rifaximin in combination with aWestern-style diet induces Ileal inflammation and enhances growth of proteobacteria in IL-10-/-mice. Gastroenterology 150, S580.
50. Chen CH, Lin CL, KaoCH(2016) Irritable bowel syndrome is associated with an increased risk of dementia: A nationwide population-based study. PLoS One 11, e0144589.
51. Erill I, Campoy S, Kilic S, Barbe J (2016) The Verrucomicrobia LexA-binding motif: Insights into the evolutionary dynamics of the SOS response. Front Mol Biosci 3, 33.
52. Sait M, Kamneva OK, Fay DS, Kirienko NV, Polek J, Shirasu-Hiza MM, Ward NL (2011) Genomic and experimental evidence suggests that Verrucomicrobium spinosum interacts with eukaryotes. Front Microbiol 2, 211.
53. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA, Florin TH (2010) Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105, 2420-2428.
54. Zella GC, Hait EJ, Glavan T, Gevers D, Ward DV, Kitts CL, Korzenik JR (2011) Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis 17, 1092-1100.
55. Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP (2013) Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8, e70803.
56. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1, 6ra14.
57. Kaakoush NO (2015) Insights into the role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol 5, 84.
58. Magnusson KR, Hauck L, Jeffrey BM, Elias V, Humphrey A, Nath R, Perrone A, Bermudez LE (2015) Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience 300, 128-140.
59. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-MattioliM(2016) Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165, 1762-1775.
60. Crost EH, Tailford LE, Monestier M, Swarbreck D, Henrissat B, Crossman LC, Juge N (2016) The mucin-degradation strategy of Ruminococcus gnavus: The importance of intramolecular trans-sialidases. Gut Microbes 7, 302-312.
61. Tailford LE, Owen CD, Walshaw J, Crost EH, Hardy-Goddard J, Le Gall G, deVosWM, Taylor GL, JugeN(2015) Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation. Nat Commun 6, 7624.
62. Graziani F, Pujol A, Nicoletti C, Dou S, Maresca M, Giardina T, Fons M, Perrier J (2016) Ruminococcus gnavus E1 modulates mucin expression and intestinal glycosylation. J Appl Microbiol 120, 1403-1417.
63. Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N (2013) Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS One 8, e76341.
64. Eeckhaut V, Machiels K, Perrier C, Romero C, Maes S, Flahou B, Steppe M, Haesebrouck F, Sas B, Ducatelle R, Vermeire S, Van Immerseel F (2013) Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745-1752.
65. Steppe M, Van Nieuwerburgh F, Vercauteren G, Boyen F, Eeckhaut V, Deforce D, Haesebrouck F, Ducatelle R, Van Immerseel F (2014) Safety assessment of the butyrateproducing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. Food Chem Toxicol 72, 129-137.
66. Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF (2016) The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem Int 99, 110-132.
67. Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A (2011) Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis 26, 187-197.
68. Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, RumbaughG(2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35, 870-880.
69. Brandscheid C, Schuck F, Reinhardt S, Schafer KH, Pietrzik CU, Grimm M, Hartmann T, Schwiertz A, Endres K (2017) Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer's mouse model. J Alzheimers Dis 56, 775-788.
70. Shen L, Liu L, JiHF(2017) Alzheimer's disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state. J Alzheimers Dis 56, 385-390.
71. Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB (2016) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49, 60-68.
72. Zong YY, Wang XY, Wang HL, Liu YL, Huang L, Ma C, Zhang LF, Qin C (2008) Continuous analysis of senile plaque and behaviour in APPswe/PS-E9 double-transgenic gene mouse model of Alzheimer disease. Chin J Comp Med 18, 8-12.